XENE Xenon Pharmaceuticals Inc.
Fundamentals / CIK 0001582313 / USDXenon Pharmaceuticals Inc. reported $0 in revenue and a net loss of $428.7M for the trailing twelve months ended September 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XENE in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Sep 30, 2026
-
Operating Income TTM-$465.3M Operating profit
-
Net Income TTM-$428.7M GAAP bottom line
-
Diluted EPS TTM-$4.30 Split-adjusted
-
Free Cash Flow TTM-$357.1M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$950.8M Total debt: $6.01M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.50M | $0 | $0 | $9.43M | $18.44M | $32.17M | $6.83M | -- | $311K | $1.80M |
| Research & Development | $300.9M | $210.4M | $167.5M | $105.8M | $75.46M | $50.52M | $38.84M | $23.63M | $25.57M | $19.83M |
| Total Operating Expenses | $380.6M | $279.3M | $214.1M | $138.6M | $97.43M | $63.47M | $49.65M | $38.04M | $32.89M | $26.62M |
| Operating Income | -$373.1M | -$279.3M | -$214.1M | -$129.1M | -$78.99M | -$31.30M | -$42.82M | -$38.04M | -$32.58M | -$24.82M |
| EBITDA | -$370.5M | -$276.7M | -$212.0M | -$127.7M | -$78.09M | -$30.66M | -$42.39M | -$37.45M | -$31.93M | -$23.95M |
| Interest Income | $26.83M | $41.94M | $27.62M | $8.71M | $466K | $2.28M | $2.35M | $1.22M | $477K | $504K |
| Interest Expense | -- | -- | -- | -- | -- | $484K | $1.43M | $1.39M | -- | -- |
| Income Before Tax | -$344.9M | -$238.4M | -$182.7M | -$125.3M | -$78.89M | -$29.09M | -$41.62M | -$34.52M | -- | -- |
| Income Tax Expense | $1.02M | -$4.09M | -$292K | $118K | -$6.0K | -$257K | -$23K | -$24K | -- | -- |
| Net Income | -$345.9M | -$234.3M | -$182.4M | -$125.4M | -$78.88M | -$28.84M | -$41.59M | -$34.50M | -$30.70M | -$23.00M |
| Basic EPS | -$4.36 | -$3.01 | -$2.73 | -$2.06 | -$1.77 | -$0.81 | -$1.54 | -$1.63 | -$1.71 | -$1.48 |
| Diluted EPS | -$4.36 | -$3.01 | -$2.73 | -$2.06 | -$1.77 | -$0.81 | -$1.54 | -$1.63 | -$1.72 | -$1.48 |
| Basic Shares Outstanding | 79.3M | 77.9M | 66.9M | 60.5M | 43.6M | 34.5M | 25.9M | 19.4M | 18.0M | 15.5M |
| Diluted Shares Outstanding | 79.3M | 77.9M | 66.9M | 60.5M | 43.6M | 34.5M | 25.9M | 19.4M | 18.0M | 15.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $7.50M | $0 |
| Research & Development | $95.64M | $99.22M | $88.51M | $87.70M | $77.05M | $74.98M | $61.20M | $59.47M |
| Total Operating Expenses | $120.1M | $123.2M | $112.3M | $109.8M | $96.34M | $94.23M | $80.24M | $77.48M |
| Operating Income | -$120.1M | -$123.2M | -$112.3M | -$109.8M | -$96.34M | -$94.23M | -$72.74M | -$77.48M |
| EBITDA | -$119.5M | -$122.6M | -$111.7M | -$109.2M | -$95.69M | -$93.60M | -$72.08M | -$76.81M |
| Interest Income | $11.62M | $12.14M | $6.91M | $5.34M | $6.21M | $7.20M | $8.08M | $9.42M |
| Income Before Tax | -$108.6M | -$111.3M | -$104.9M | -$104.7M | -$90.22M | -$85.33M | -$64.62M | -$69.53M |
| Income Tax Expense | $1.84M | -$585K | -$2.57M | $538K | $677K | -$626K | $427K | -$3.85M |
| Net Income | -$110.4M | -$110.7M | -$102.3M | -$105.3M | -$90.90M | -$84.71M | -$65.05M | -$65.69M |
| Basic EPS | -$1.11 | -$1.11 | -$1.17 | -- | -$1.15 | -$1.07 | -$0.83 | -- |
| Diluted EPS | -$1.11 | -$1.11 | -$1.17 | -- | -$1.15 | -$1.07 | -$0.83 | -- |
| Basic Shares Outstanding | 99.8M | 99.6M | 87.3M | -- | 79.2M | 79.0M | 78.7M | -- |
| Diluted Shares Outstanding | 99.8M | 99.6M | 87.3M | -- | 79.2M | 79.0M | 78.7M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $199.2M | $142.7M | $148.6M | $57.24M | $175.7M | $45.01M | $24.75M | $67.75M | $20.49M | $17.09M |
| Short-Term Investments | $349.7M | $484.2M | $489.4M | $534.8M | $376.1M | $132.0M | $116.6M | $51.55M | $23.18M | $47.05M |
| Cash & Short-Term Investments | $548.9M | $626.9M | $638.1M | $592.1M | $551.8M | $177.0M | $141.4M | $119.3M | $43.67M | $64.15M |
| Accounts Receivable, Net | -- | $1.47M | $874K | $986K | $2.77M | $1.82M | $813K | $151K | $438K | $200K |
| Total Current Assets | $560.6M | $635.3M | $645.0M | $600.3M | $559.0M | $181.8M | $144.9M | $121.3M | $44.82M | $65.67M |
| Property, Plant & Equipment, Net | $8.72M | $10.28M | $9.65M | $6.50M | $4.47M | $3.55M | $1.66M | $991K | $1.07M | $1.40M |
| Long-Term Investments | $37.15M | $127.5M | $292.8M | $128.7M | $0 | -- | -- | -- | -- | -- |
| Total Non-Current Assets | $72.51M | $162.9M | $319.8M | $153.8M | $12.99M | $7.40M | $2.83M | $1.10M | $1.30M | $1.81M |
| Total Assets | $633.2M | $798.1M | $964.8M | $754.1M | $572.0M | $189.2M | $147.7M | $122.4M | $46.12M | $67.49M |
| Accounts Payable | $3.88M | $5.07M | $8.60M | $8.49M | $3.82M | $3.04M | $2.47M | $665K | $1.25M | $1.46M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $4.65M | -- | $700K | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $3.64M | $29.74M | -- | -- | -- |
| Total Current Liabilities | $41.79M | $35.59M | $27.27M | $22.70M | $14.32M | $14.78M | $43.38M | $4.12M | $4.08M | $3.59M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | $10.89M | $15.01M | $6.10M | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | $709K | -- | -- | -- |
| Other Non-Current Liabilities | $3.20M | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $9.61M | $7.65M | $9.60M | $9.95M | $7.65M | $3.05M | $12.34M | $15.01M | $6.10M | $0 |
| Total Liabilities | $51.40M | $43.24M | $36.88M | $32.65M | $21.97M | $17.83M | $55.72M | $19.13M | $10.19M | $3.59M |
| Total Debt (incl. Leases) | $7.94M | $9.02M | $10.90M | $10.44M | $8.26M | $3.31M | $16.45M | $15.01M | $6.80M | -- |
| Common Stock | $1.60B | $1.46B | $1.44B | $1.07B | $783.2M | $397.7M | $294.2M | $265.9M | $173.8M | $173.2M |
| Retained Earnings | -$1.25B | -$899.5M | -$665.1M | -$482.7M | -$357.4M | -$278.5M | -$249.7M | -$207.9M | -$173.4M | -$142.7M |
| Accumulated Other Comp. Income | $335K | -$1.61M | -$77K | -$3.00M | -$990K | -$990K | -$990K | -$990K | -$990K | -$990K |
| Total Stockholders' Equity | $581.8M | $754.9M | $927.9M | $721.5M | $550.0M | $171.4M | $91.98M | $103.3M | $35.93M | $63.90M |
| Total Equity | $581.8M | $754.9M | $927.9M | $721.5M | $550.0M | $171.4M | $91.98M | $103.3M | $35.93M | $63.90M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $82.56M | $119.5M | $545.9M | $199.2M | $104.5M | $135.4M | $116.7M | $142.7M |
| Short-Term Investments | $868.2M | $811.2M | $548.9M | $349.7M | $357.8M | $352.2M | $433.0M | $484.2M |
| Cash & Short-Term Investments | $950.8M | $930.7M | $1.09B | $548.9M | $462.3M | $487.5M | $549.6M | $626.9M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | -- | $1.47M |
| Total Current Assets | $960.1M | $945.9M | $1.11B | $560.6M | $480.1M | $500.3M | $565.5M | $635.3M |
| Property, Plant & Equipment, Net | $7.46M | $7.77M | $8.29M | $8.72M | $8.89M | $9.21M | $9.70M | $10.28M |
| Long-Term Investments | $202.7M | $314.4M | $244.9M | $37.15M | $92.99M | $137.3M | $141.5M | $127.5M |
| Total Non-Current Assets | $239.8M | $349.9M | $280.2M | $72.51M | $127.7M | $174.0M | $177.7M | $162.9M |
| Total Assets | $1.20B | $1.30B | $1.39B | $633.2M | $607.8M | $674.3M | $743.3M | $798.1M |
| Accounts Payable | $1.93M | $2.48M | $5.75M | $3.88M | $4.55M | $4.79M | $6.88M | $5.07M |
| Total Current Liabilities | $45.30M | $45.01M | $39.81M | $41.79M | $38.34M | $33.05M | $32.03M | $35.59M |
| Other Non-Current Liabilities | $3.33M | $3.29M | $3.25M | $3.20M | $3.16M | -- | -- | $0 |
| Total Non-Current Liabilities | $8.19M | $8.37M | $9.18M | $9.61M | $9.99M | $7.26M | $7.29M | $7.65M |
| Total Liabilities | $53.49M | $53.38M | $48.99M | $51.40M | $48.33M | $40.30M | $39.32M | $43.24M |
| Total Debt (incl. Leases) | $6.01M | $6.42M | $7.49M | $7.94M | $8.33M | $8.71M | $8.68M | $9.02M |
| Common Stock | $2.49B | $2.43B | $2.42B | $1.60B | $1.48B | $1.47B | $1.46B | $1.46B |
| Retained Earnings | -$1.57B | -$1.46B | -$1.35B | -$1.25B | -$1.14B | -$1.05B | -$964.5M | -$899.5M |
| Accumulated Other Comp. Income | -$5.05M | -$2.66M | -$1.21M | $335K | $477K | $113K | -$836K | -$1.61M |
| Total Stockholders' Equity | $1.15B | $1.24B | $1.34B | $581.8M | $559.5M | $634.0M | $704.0M | $754.9M |
| Total Equity | $1.15B | $1.24B | $1.34B | $581.8M | $559.5M | $634.0M | $704.0M | $754.9M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$345.9M | -$234.3M | -$182.4M | -$125.4M | -$78.88M | -$28.84M | -$41.59M | -$34.50M | -$30.70M | -$23.00M |
| Depreciation & Amortization | $2.54M | $2.56M | $2.06M | $1.41M | $906K | $644K | $429K | $586K | $649K | $864K |
| Stock-Based Compensation | $53.71M | $50.72M | $32.37M | $20.38M | $10.02M | $5.68M | $2.92M | $2.62M | $2.24M | $2.16M |
| Change in Receivables | -- | -$614K | $130K | $1.76M | -$459K | -$1.03M | -$653K | $280K | -$232K | $121K |
| Operating Cash Flow | -$279.1M | -$181.4M | -$151.1M | -$101.0M | -$69.50M | -$48.12M | -$4.71M | -$34.72M | -$28.73M | -$19.57M |
| Capital Expenditure | -$799K | -$3.08M | -$5.62M | -$2.89M | -$2.05M | -$2.64M | -$1.24M | -$507K | -$315K | -$279K |
| Free Cash Flow | -$279.9M | -$184.5M | -$156.7M | -$103.9M | -$71.55M | -$50.76M | -$5.95M | -$35.23M | -$29.04M | -$19.85M |
| Purchases of Investments | -$355.7M | -$532.3M | -$793.9M | -$551.1M | -$389.5M | -$228.9M | -$140.5M | -$77.00M | -$28.01M | -$47.56M |
| Investing Cash Flow | $218.0M | $165.0M | -$111.4M | -$293.4M | -$246.8M | -$16.82M | -$66.21M | -$28.99M | $24.29M | -$47.84M |
| Common Stock Issued | -- | -- | -- | -- | -- | $102.5M | $27.40M | $102.8M | -- | $23.83M |
| Financing Cash Flow | $117.1M | $12.13M | $353.5M | $278.5M | $447.5M | $85.80M | $27.52M | $111.6M | $7.07M | $23.96M |
| Net Change in Cash | $56.45M | -$5.93M | $91.40M | -$118.4M | $130.7M | $20.25M | -$43.00M | $47.27M | $3.39M | -$41.56M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$110.4M | -$110.7M | -$102.3M | -$105.3M | -$90.90M | -$84.71M | -$65.05M | -$65.69M |
| Depreciation & Amortization | $562K | $558K | $587K | $611K | $641K | $632K | $659K | $666K |
| Stock-Based Compensation | $16.55M | $16.73M | $16.89M | $14.12M | $13.71M | $13.71M | $12.17M | $13.60M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | -$547K |
| Operating Cash Flow | -$90.33M | -$95.39M | -$88.90M | -$81.48M | -$71.75M | -$64.23M | -$61.65M | -$54.38M |
| Capital Expenditure | -$284K | -$275K | -$133K | -$318K | -$281K | -$157K | -$43K | -$783K |
| Free Cash Flow | -$90.61M | -$95.67M | -$89.03M | -$81.80M | -$72.03M | -$64.39M | -$61.70M | -$55.17M |
| Purchases of Investments | -$169.6M | -$490.4M | -$505.7M | -$60.90M | -$74.70M | -$88.82M | -$131.2M | -$66.35M |
| Investing Cash Flow | $53.19M | -$331.2M | -$407.3M | $62.70M | $38.53M | $82.26M | $34.51M | $98.50M |
| Financing Cash Flow | $228K | $26K | $843.0M | $113.5M | $2.36M | $65K | $1.15M | $12.13M |
| Net Change in Cash | -$36.97M | -$426.3M | $346.7M | $94.65M | -$30.87M | $18.72M | -$26.05M | $55.09M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -4974.3% | -- | -- | -1368.9% | -428.4% | -97.3% | -627.0% | -- | -10474.3% | -1376.4% |
| Net Profit Margin | -4612.1% | -- | -- | -1328.9% | -427.8% | -89.7% | -609.1% | -- | -9872.7% | -1275.5% |
| Return on Equity (ROE) | -59.5% | -31.0% | -19.7% | -17.4% | -14.3% | -16.8% | -45.2% | -33.4% | -85.4% | -36.0% |
| Return on Assets (ROA) | -54.6% | -29.4% | -18.9% | -16.6% | -13.8% | -15.2% | -28.2% | -28.2% | -66.6% | -34.1% |
| Current Ratio | 13.42x | 17.85x | 23.65x | 26.44x | 39.03x | 12.30x | 3.34x | 29.46x | 10.98x | 18.31x |
| Quick Ratio | 13.13x | 17.66x | 23.43x | 26.12x | 38.72x | 12.10x | 3.28x | 29.00x | 10.80x | 17.94x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x | 0.02x | 0.18x | 0.15x | 0.19x | -- |
| Revenue Growth (YoY) | -- | -- | -100.0% | -48.8% | -42.7% | +371.0% | -- | -- | -82.8% | -88.4% |
| 5Y Revenue / Share Growth | -89.8% | -100.0% | -- | +801.1% | +263.1% | -14.6% | -97.1% | -- | -99.8% | -- |
| 10Y Revenue / Share Growth | -91.3% | -100.0% | -100.0% | -98.6% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -139.0% | -119.7% | -- | -- |
| 10Y Net Income / Share Growth | -- | -173.2% | -130.3% | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -4974.3% | -4543.7% | -4241.6% | -3906.6% | -- |
| Net Profit Margin | -- | -- | -- | -4612.1% | -4084.5% | -3709.7% | -3352.6% | -- |
| Return on Equity (ROE) | -37.4% | -32.9% | -28.6% | -59.5% | -54.8% | -43.9% | -35.7% | -31.0% |
| Return on Assets (ROA) | -35.7% | -31.6% | -27.6% | -54.6% | -50.4% | -41.3% | -33.8% | -29.4% |
| Current Ratio | 21.19x | 21.02x | 27.79x | 13.42x | 12.52x | 15.14x | 17.66x | 17.85x |
| Quick Ratio | 20.99x | 20.68x | 27.50x | 13.13x | 12.06x | 14.75x | 17.16x | 17.66x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |
| Revenue Growth (YoY) | -- | -- | -100.0% | -- | -- | -- | -- | -- |